Skip to main content

Find Clinical Trials

Home
Conditions
Bioequivalence

Clinical trial condition

Bioequivalence

Explore clinical trials studying Bioequivalence. Study availability and eligibility vary by location and protocol.

143 public trials 2 recruiting studies

Refine in advanced search Browse all conditions

Bioequivalence trial results

Completed

A Pharmacokinetic and Bioequivalence Study of Savolitinib Tablets in Healthy Chinese Male Volunteers

NCT03860948

Conditions: Bioequivalence
Locations: Shanghai Xuhui District Central Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Completed

Bioequivalence Study of Clavamox, Film-coated Tablets, 875 mg + 125 mg Pharmtechnology LLC, Belarus), and Augmentin®, Film-coated Tablets, 875 mg + 125 mg (GlaxoSmithKline Trading CJSC, Russia), in Healthy Volunteers Under Fasting Conditions

NCT03702894

Conditions: Bioequivalence
Locations: State Autonomous Healthcare Facility of the Yaroslavl Region "Clinical Hospital No. 2" Yaroslavl, Yaroslavl Oblast, Russia

View Trial Details

Completed

Comparison of Two Formulations of Androxal

NCT01984398

Conditions: Bioequivalence
Locations: Clinical Pharmacology of miami Miami, Florida, United States

View Trial Details

Completed

A Bioequivalence Study Between Fluticasone Propionate 250 mcg and Salmeterol Xinafoate 50 mcg Inhalation Powder/Respirent Pharmaceuticals vs. ADVAIR DISKUS® 250/50 Inhalation Powder/GSK in Healthy Volunteers

NCT03820180

Conditions: Bioequivalence
Locations: BECRO Clinical Facility Larissa, Thessaly, Greece

View Trial Details

Completed

Bioequivalence (BE) Study Comparing Azithromycin 250 mg Tablet Manufactured in China and in the United States

NCT03353480

Conditions: Bioequivalence
Locations: The First Hospital of Jilin University/Phase I Clinical Trials Unit Changchun, Jilin, China

View Trial Details

Completed

Bioavailability of ATI-1501 With Taste Test Sub Study

NCT03337126

Conditions: Bioequivalence
Locations: INC Research Inc. Toronto, Ontario, Canada

View Trial Details

Completed

Bioequivalence of Imeglimin Tablet Formulations

NCT03646331

Conditions: Bioequivalence
Locations: Hammersmith Medicines Research (HMR) London, United Kingdom

View Trial Details

Completed

A Bioequivalence Study Between Fluticasone Salmeterol Xinafoate vs. ADVAIR DISKUS® in Healthy Volunteers

NCT03751202

Conditions: Bioequivalence
Locations: BECRO Clinical Facility Larissa, Thessaly, Greece

View Trial Details

Completed

Bioequivalence Study of Two Formulations of Telmisartan 80 mg Tablets in Healthy Adult Volunteers Under Fasting State

NCT03705533

Conditions: Bioequivalence
Locations: Algorithme Pharma, An Altasciences Company Mount Royal, Quebec, Canada

View Trial Details

Completed

Bioequivalence Study of Clavamox, Powder for Oral Suspension, 400 mg + 57 mg / 5 ml (Pharmtechnology LLC, Belarus), and Augmentin®, Powder for Oral Suspension, 400 mg + 57 mg / 5 ml (GlaxoSmithKline Trading CJSC, Russia), in Healthy Volunteers Under Fasting Conditions

NCT03616301

Conditions: Bioequivalence
Locations: State Autonomous Healthcare Facility of the Yaroslavl Region "Clinical Hospital No. 2" Yaroslavl, Yaroslavl Oblast, Russia

View Trial Details